BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institut Jacques Monod - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Institut Jacques Monod
X-ORIGINAL-URL:https://www.ijm.fr
X-WR-CALDESC:Évènements pour Institut Jacques Monod
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260612T110000
DTEND;TZID=Europe/Paris:20260612T120000
DTSTAMP:20260607T222753
CREATED:20260602T094657Z
LAST-MODIFIED:20260602T094657Z
UID:33288-1781262000-1781265600@www.ijm.fr
SUMMARY:Séminaire de l'Institut Jacques Monod - Laurent Blanchoin & Manuel Théry
DESCRIPTION:Invité par l’équipe Romet-Lemonne/Jégou\, Manuel Théry (Directeur de Recherche CEA\, Cytomorpholab\, ESPCI/IPGG\, Paris) et Laurent Blanchoin (Directeur de Recherche CNRS\, Cytomorpholab\, IRIG/LPCV\, Grenoble) présenteront un séminaire de l’Institut Jacques Monod sur le thème : \nThe self-renewing cell: how actin networks are built\, sized\, and dismantled \nRésumé : \nThe actin cytoskeleton continuously assembles and disassembles its filaments\, a process of self-renewal essential for cell shape\, movement\, and response to the environment. Yet how the cell coordinates this renewal across multiple coexisting actin structures\, and what sets the rate at which individual networks turn over\, remains poorly understood. Using a minimal reconstituted system with either unlimited or limited monomer availability\, we show that when monomers are scarce\, competition between distinct actin architectures profoundly disrupts turnover: as competition increases\, the turnover rate of individual networks decreases. Actin turnover is therefore not an intrinsic property of individual networks but an emergent outcome dictated by the competitive balance between coexisting architectures. We then show that this principle operates in living cells: when cells increase their spreading area\, the expanding cytoskeleton monopolizes available monomers\, forcing a slowing of turnover at the whole-cell scale. Together\, these results establish competition between actin structures as a fundamental determinant of turnover\, revealing how the global cytoskeletal state collectively shapes the dynamic properties of each individual network
URL:https://www.ijm.fr/event/seminaire-de-linstitut-jacques-monod-laurent-blanchoin-manuel-thery/
LOCATION:Institut Jacques Monod Salle François Jacob\, 15 rue Hélène Brion\, Paris\, 75013\, France
ATTACH;FMTTYPE=image/jpeg:https://www.ijm.fr/wp-content/uploads/2026/06/Bandeau-web-seminar-Laurent-Blanchoin-Manuel-Thery-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260612T140000
DTEND;TZID=Europe/Paris:20260612T170000
DTSTAMP:20260607T222753
CREATED:20260522T145207Z
LAST-MODIFIED:20260522T145207Z
UID:33260-1781272800-1781283600@www.ijm.fr
SUMMARY:Soutenance HDR - Hugo Wioland
DESCRIPTION:Hugo Wioland (équipe Romet-Lemonne/Jégou) va défendre son Habilitation à Diriger des recherche : \nActin biochemical and mechanical diversity \nLe jury sera composé de : \n\nNicolas Joly\, Président\nLaurent Blanchoin\, Rapporteur\nPeter Bieling\, Rapporteur\nAurélie Bertin\, Examinatrice\nPatricia Bassereau\, Examinatrice
URL:https://www.ijm.fr/event/soutenance-hdr-hugo-wioland/
LOCATION:Institut Jacques Monod Salle François Jacob\, 15 rue Hélène Brion\, Paris\, 75013\, France
ATTACH;FMTTYPE=image/jpeg:https://www.ijm.fr/wp-content/uploads/2026/05/HDR-bandeau-Hugo-Wioland-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260617T093000
DTEND;TZID=Europe/Paris:20260617T110000
DTSTAMP:20260607T222753
CREATED:20260605T115913Z
LAST-MODIFIED:20260605T115913Z
UID:33346-1781688600-1781694000@www.ijm.fr
SUMMARY:Cytoskeleton club
DESCRIPTION:La prochaine réunion du cytoskeleton club aura lieu mercredi 17 juin. \n\nLucas PRADEAU-PHELUT (PhD student\, S. Etienne-Manneville’s group\, Institut Pasteur) présentera « Synemin–MARK2 interaction: a key regulator of cytoskeletal crosstalk during glioblastoma cell adhesion\, migration\, and invasion. »\nBhagyanath Suresh (Ph Student\, M. Thery’s group\, IPGG) présentera « From morphogenesis to space partitioning »
URL:https://www.ijm.fr/event/cytoskeleton-club-16/
LOCATION:Institut Jacques Monod Salle François Jacob\, 15 rue Hélène Brion\, Paris\, 75013\, France
ATTACH;FMTTYPE=image/jpeg:https://www.ijm.fr/wp-content/uploads/2026/06/20260617-bandeau-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260623T140000
DTEND;TZID=Europe/Paris:20260623T170000
DTSTAMP:20260607T222753
CREATED:20260603T143401Z
LAST-MODIFIED:20260603T143556Z
UID:33313-1782223200-1782234000@www.ijm.fr
SUMMARY:Soutenance de thèse - Aurélie Masson
DESCRIPTION:Aurélie Masson (équipe Prioleau) va défendre sa thèse : \nCartographie des sites fragiles communs potentiels dans les précurseurs neuronaux et étude de leur impact sur le développement du cortex cérébral \nLe jury sera composé de : \nPatricia KANNOUCHE\, DR\, Université Paris-Saclay\, Rapportrice.\nPhilippe PASERO\, DR\, Université de Montpellier\, Rapporteur.\nSara BIZZOTTO\, CR\, Université Paris Cité\, Examinatrice.\nStéphane KOUNDRIOUKOFF\, PU\, Université d’Orléans\, Examinateur.\nJean-Charles CADORET\, PU\, Université Paris Cité\, Examinateur.\nMarie-Noëlle PRIOLEAU\, DR\, Université Paris Cité\, Directrice de thèse.
URL:https://www.ijm.fr/event/soutenance-de-these-aurelie-masson/
LOCATION:Amphithéâtre Alan Turing – Bâtiment Sophie Germain\, 8 place Aurélie Nemours\, Paris\, 75013\, France
ATTACH;FMTTYPE=image/jpeg:https://www.ijm.fr/wp-content/uploads/2026/06/These-bandeau-Aurelie-Masson.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260626T114500
DTEND;TZID=Europe/Paris:20260626T130000
DTSTAMP:20260607T222753
CREATED:20260522T145834Z
LAST-MODIFIED:20260522T150044Z
UID:33267-1782474300-1782478800@www.ijm.fr
SUMMARY:Séminaire de l'Institut Jacques Monod - Christian Schlieker
DESCRIPTION:Invité par l’équipe Palancade\, Christian Schlieker (Department of Molecular Biophysics and Biochemistry\, Yale University\, USA) présentera un séminaire de l’Institut Jacques Monod sur le thème : \nBiomolecular Condensates at the Nuclear Envelope: From Mechanism to Therapeutic Modulation \nChristian started his scientific training as an undergraduate at the University of Bonn in Germany\, with a research stay at the University of New South Wales in Sydney\, Australia. He then earned his Ph.D. in the laboratory of Dr. Bernd Bukau at the Center for Molecular Biology (ZMBH) of Heidelberg University\, where he used biochemical and biophysical approaches to uncover how Clp/HSP100 AAA+ ATPases counteract proteotoxic stress. \nChristian continued his training as an EMBO postdoctoral fellow with Dr. Hidde Ploegh at Harvard Medical School and the Whitehead Institute/MIT\, where he explored the ubiquitin–proteasome system and discovered a novel role for a ubiquitin-like modifier in RNA biology. \nChristian joined the Department of Molecular Biophysics and Biochemistry at Yale University in 2009\, where he is currently Professor and Director of Undergraduate Studies\, with a secondary appointment in the Department of Cell Biology. He is a recipient of the NIH Director’s New Innovator Award and has served on the scientific advisory board of the Dystonia Medical Research Foundation and reviewed for the NIH\, the Department of Defense\, the German Excellence Initiative\, ANR and the European Research Council\, among others. At Yale\, he has chaired the Committee on Majors for Yale College and currently serves on the Advisory Board of the Yale Center for Molecular Discovery. Starting in July 2026\, he will chair the Department of Molecular Biophysics and Biochemistry. \nBrief synopsis \nWe explore how cells build and safeguard two the nuclear envelope and the endoplasmic reticulum. Our work focuses on how disruptions in membrane organization and phase separation drive the formation of aberrant condensates that are increasingly implicated in neurological disease. To tackle these questions\, we develop and apply new tools that allow us to probe and modulate these processes across scales\, from the dynamics of individual proteins and condensates to genome-wide functional screens. By integrating cell biology\, biochemistry\, and computational approaches with patient-derived and animal model systems\, we aim to uncover fundamental principles of cellular organization and translate these discoveries into novel therapeutic strategies for movement disorders and related conditions. \nWe recently developed a high-content platform and computational pipeline to screen modulators of nuclear condensates across chemical and genetic space. This effort identified novel players in nuclear condensates formation\, along with small molecules that modualte proteotoxic condensates. Application of the platform in a genome-wide CRISPR knockout screen revealed strong enrichment of candidate genes linked to primary microcephaly and related neurodevelopmental disorders\, pointing to condensate dysregulation as a shared molecular axis across disease. \nA complementary line of work asks how the nuclear pore complex itself contributes to protein quality control. Co-translational folding allows nascent proteins to begin folding as they are synthesized\, reducing the risk of aggregation and avoiding energy-intensive unfolding steps. We propose that karyopherins and flexible FG-nucleoporins not only safeguard the nuclear permeability barrier but also generate a supportive environment — a “folding phase” — that promotes correct folding of proteins entering the nucleus. This perspective offers new insight into how disruptions in nuclear transport and protein quality control may contribute to neurological disease. Together\, these efforts may inform biotechnological advances in protein stability and targeted therapeutics for diseases of disrupted folding. \nSelected publications \n\nProphet SM\, Rampello AJ\, Niescier RF\, Gentile JE\, Mallik S\, Koleske AJ\, Schlieker C: Atypical nuclear envelope condensates linked to neurological disorders reveal nucleoporin-directed chaperone activities. Nat Cell Biol 2022\, 24:1630–1641.\nPoch D\, Mukherjee C\, Mallik S\, Todorow V\, Kuiper EFE\, Dhingra N\, Surovtseva YV\, Schlieker C: Integrative Chemical Genetics Platform Identifies Condensate Modulators Linked to Neurological Disorders. bioRxiv 2025\, doi:10.1101/2025.06.07.658469.\nRampello AJ\, Laudermilch E\, Vishnoi N\, Prophet SM\, Shao L\, Zhao C\, Lusk CP\, Schlieker C: Torsin ATPase deficiency leads to defects in nuclear pore biogenesis and sequestration of MLF2. J Cell Biol 2020\, 219:e201910185.\nMallik S\, Poch D\, Burick S\, Schlieker C: Protein folding and quality control during nuclear transport. Curr Opin Cell Biol 2024\, 90:102407.
URL:https://www.ijm.fr/event/seminaire-de-linstitut-jacques-monod-christian-schlieker/
LOCATION:Institut Jacques Monod Salle François Jacob\, 15 rue Hélène Brion\, Paris\, 75013\, France
ATTACH;FMTTYPE=image/jpeg:https://www.ijm.fr/wp-content/uploads/2026/05/Bandeau-web-seminar-Christian-Schlieker-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260706
DTEND;VALUE=DATE:20260707
DTSTAMP:20260607T222753
CREATED:20260520T132700Z
LAST-MODIFIED:20260520T132700Z
UID:33219-1783296000-1783382399@www.ijm.fr
SUMMARY:DIF Day 2026
DESCRIPTION:Les inscriptions pour le DIF day 2026 sont ouvertes ! \nRendez-vous sur le site d’inscriptions pour pouvoir y participer : https://sites.google.com/view/dif2026/accueil_2026?authuser=0
URL:https://www.ijm.fr/event/dif-day-2026/
LOCATION:Institut Jacques Monod Amphithéâtre Buffon\, 15 rue Hélène Brion\, Paris\, 75013\, France
ATTACH;FMTTYPE=image/jpeg:https://www.ijm.fr/wp-content/uploads/2026/05/Bandeau-DIF-2026-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260921
DTEND;VALUE=DATE:20260926
DTSTAMP:20260607T222753
CREATED:20260327T133451Z
LAST-MODIFIED:20260327T153936Z
UID:32584-1789948800-1790380799@www.ijm.fr
SUMMARY:Conférence Jacques Monod - The mechanistic and evolutionary basis of programmed DNA elimination
DESCRIPTION:The Conférence Jacques Monod  » The mechanistic and evolutionary basis of programmed DNA elimination » will take place from Monday\, September 21\, 2026toFriday\, September 25\, 2026 in Roscoff (Bretagne\, France). \n\n\n\n\nAbstracts submission deadline : Tuesday\, May 5\, 2026\n\n\nDeadline for payment of registration fees : July 2\, 2026\n\n\nDeadline for return of completed forms : July 2\, 2026\n\n\n\n\n\n\nRegistration and abstract submission website  \n\n\n\nBeyond mutations\, the genetic content of an organism is generally constant across cells throughout development. Programmed DNA elimination (PDE) – a process in which specific cell lineages lose DNA segments or whole chromosomes – represents is a striking deviation to this principle. \n\nPDE is widespread in eukaryotes and plays roles in a variety of cellular processes\, including gene silencing\, germline differentiation\, genome defence\, and non-Mendelian inheritance. It manifests in diverse biological contexts\, including the formation of germline-limited genomes\, meiotic elimination of parental chromosomes\, and sex determination via X-chromosome loss. \nIn recent years\, it has become increasingly clear that PDE occurs across a wide range of phylogenetic groups\, and involves diverse mechanisms.  These findings underscore the overlooked plasticity of genome integrity\, and reveal significant gaps in our understanding of why PDE has evolved repeatedly and is maintained across the Tree of Life. \nThis conference is designed to present the latest research on the mechanisms and evolution of PDE – from the molecular pathways that control genome stability and chromosome segregation\, to genomic conflicts and the long-term evolutionary consequences of PDE on population dynamics and species diversification. We also welcome researchers studying related phenomena\, such as meiotic drive\, B chromosomes\, and those that work on the mechanisms and regulation of genome stability\, chromosome segregation and germline development. \nThe meeting will address the following key topics: \n\n Mechanisms and regulation of genome stability and instability\nMechanisms of chromosome segregation and missegregation\nGenomic conflicts\nEvolutionary dynamics of programmed DNA elimination
URL:https://www.ijm.fr/event/conference-jacques-monod-the-mechanistic-and-evolutionary-basis-of-programmed-dna-elimination/
LOCATION:Roscoff\, Roscoff\, France
ATTACH;FMTTYPE=image/jpeg:https://www.ijm.fr/wp-content/uploads/2026/03/SD-1-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261116
DTEND;VALUE=DATE:20261118
DTSTAMP:20260607T222753
CREATED:20260309T141643Z
LAST-MODIFIED:20260309T142602Z
UID:32489-1794787200-1794959999@www.ijm.fr
SUMMARY:Ctrl+Epi+Edit\, Engineering the Epigenome
DESCRIPTION:Epigenome editing is a rapidly emerging field that has the potential to revolutionise genomic medicine by offering new ways to precisely program gene expression and treat a range of diseases. Precision control of the epigenome and gene activity is further unlocking key mechanistic insights into a wide variety of molecular and cellular processes. The potential of epigenome editing technologies for both research and therapeutic applications has thus led to widespread excitement over the last five years\, in areas ranging from neurobiology\, to high-throughput (epi)genomics to agriculture. As the technologies continue to emerge and the epigenome editing field begins to coalesce\, we feel now is the time to bring interdisciplinary experts and leaders in the field together. This will enable\, for the first time\, epigenome editors and related disciplines to collectively discuss the technology\, its applications and ethics\, and the exciting scientific insights being generated. Such a symposium will help to accelerate progress in this field by facilitating collaborations between researchers and providing a platform for the dissemination of new discoveries and techniques. It will also help to raise broader awareness of this exciting emerging science and its potential to transform precision medicine. \n\n\n\n\nTime and Place\n\nThe meeting will take place from November 16-17  at Institut Jacques Monod in the heart of Paris\, France \nWe will have two half day sessions\, and a poster session over cocktails and light bites \n\n\n\nKey Dates\n\n\nAbstract Submission: October 1\, 2026 \nRegistration: November 9\, 2026 \n\n\n\n\nInvited Speakers\n\n🧬 Gabriella Ficz (QMUL\, UK) \n🧬 Charles Gersbach (Duke University\, USA) \n🧬 Jamie Hackett (EMBL Rome\, Italy) \n🧬 Jake Harris (Cambridge University\, UK) \n🧬 Angelo Lombardo (San Raffaele University\, Italy) \n🧬 Reini Luco (Institut Curie\, France) \n🧬 Mariane Rots (UMCG\, Netherlands) \n🧬 Edda Schulz (MPI Berlin\, Germany) \n🧬 Stefan Stricker (Helmholtz Munich\, Germany) \nMore speakers will be selected from abstracts! \nYou can find all the informations regarding the symposium\, the registration and abstract submission here  \nFlyer of the event: here
URL:https://www.ijm.fr/event/ctrlepiedit-engineering-the-epigenome/
LOCATION:Institut Jacques Monod Amphithéâtre Buffon\, 15 rue Hélène Brion\, Paris\, 75013\, France
ATTACH;FMTTYPE=image/jpeg:https://www.ijm.fr/wp-content/uploads/2026/03/web-image-bandeau-1.jpg
END:VEVENT
END:VCALENDAR